Changing pattern of the use of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
14/08/2023
Carlos Sánchez-Piedra1, Águeda Prior-Español2, Mercedes Freire González3, María Colazo4, Dolores Ruiz-Montesinos5, Yanira Perez-Vera6, Ana Ortiz7, Sagrario Bustabad8, Paloma Vela-Casasempere9, Marta Rojas-Giménez10, Fernando Sánchez-Alonso1, Federico Diaz-Gonzalez1, Juan Jesus Gomez-Reino11, BIOBADASER group
EULAR 2019
DOI: 10.1136/annrheumdis-2019-eular.3181
http://scientific.sparx-ip.net/archiveeular/?c=a&searchfor=sanchez-piedra&view=1&item=2019SAT0159